X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
index medicus (75) 75
alzheimer's disease (60) 60
male (58) 58
female (57) 57
neurosciences (53) 53
aged (46) 46
middle aged (37) 37
aged, 80 and over (34) 34
brain (30) 30
animals (28) 28
clinical neurology (28) 28
dementia (25) 25
neurodegenerative diseases (23) 23
alzheimers-disease (21) 21
adult (20) 20
alzheimer disease - pathology (19) 19
brain - pathology (19) 19
mice (19) 19
proteins (19) 19
pathology (18) 18
alzheimer’s disease (16) 16
immunohistochemistry (16) 16
neurons (16) 16
research (16) 16
alzheimer disease - genetics (15) 15
brain - metabolism (15) 15
creutzfeldt-jakob disease (15) 15
neurology (15) 15
association (14) 14
cerebrospinal-fluid (14) 14
neuropathology (14) 14
case-control studies (13) 13
diagnosis (13) 13
neurodegeneration (13) 13
research article (13) 13
tau (13) 13
alzheimer disease - metabolism (12) 12
analysis (12) 12
genetic aspects (12) 12
protein (12) 12
risk factors (12) 12
biochemistry & molecular biology (11) 11
development and progression (11) 11
hippocampus (11) 11
multidisciplinary sciences (11) 11
alzheimers disease (10) 10
expression (10) 10
medicine (10) 10
neurons - metabolism (10) 10
neurons - pathology (10) 10
tau proteins - metabolism (10) 10
epidemiology (9) 9
fungal infection (9) 9
mental disorders (9) 9
pathogenesis (9) 9
phosphorylation (9) 9
cerebrospinal fluid (8) 8
disease models, animal (8) 8
gene expression (8) 8
inflammation (8) 8
mutation (8) 8
nervous system diseases (8) 8
parkinson's disease (8) 8
physiological aspects (8) 8
prion protein (8) 8
science (8) 8
alzheimer disease - diagnosis (7) 7
amyloid precursor protein (7) 7
amyotrophic lateral sclerosis (7) 7
antibodies (7) 7
biomarkers (7) 7
frontotemporal dementia (7) 7
gene-expression (7) 7
mice, transgenic (7) 7
model (7) 7
mouse model (7) 7
nervous system (7) 7
neurogenesis (7) 7
neuroprotection (7) 7
phenotype (7) 7
psychiatry (7) 7
surgery (7) 7
alzheimer disease (6) 6
alzheimer disease - complications (6) 6
apolipoproteins e - genetics (6) 6
article (6) 6
dentate gyrus (6) 6
disease (6) 6
disease progression (6) 6
frontotemporal lobar degeneration (6) 6
geriatrics & gerontology (6) 6
hospitals (6) 6
metabolism (6) 6
mild cognitive impairment (6) 6
mutations (6) 6
national institute (6) 6
neurodegenerative disease (6) 6
parkinsons-disease (6) 6
polymerase chain reaction (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e43926
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 02/2018, Volume 89, Issue 2, pp. 162 - 168
Journal Article
Nature Medicine, ISSN 1078-8956, 2019, Volume 25, Issue 4, pp. 554 - 560
The hippocampus is one of the most affected areas in Alzheimer’s disease (AD)1. Moreover, this structure hosts one of the most unique phenomena of the adult... 
Controlled conditions | Brain | Dentate gyrus | Maturation | Neurons | Identification methods | Aging | Physiology | Plasticity (hippocampal) | Neurogenesis | Alzheimer's disease | Hippocampus
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 07/2016, Volume 25, Issue 2, pp. 61 - 77
Aims: This preclinical study was aimed at determining whether pharmacological targeting of transcription factor NRF2, a master controller of many homeostatic... 
Original Research Communications | OXIDATIVE STRESS | IN-VITRO | TRANSCRIPTION FACTOR NRF2 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | MPTP MOUSE MODEL | ALPHA-SYNUCLEIN | HEME OXYGENASE-1 | AUTOPHAGY | NF-KAPPA-B | EXPRESSION | NEUROPROTECTION | Immunohistochemistry | NF-E2-Related Factor 2 - agonists | Parkinson Disease - drug therapy | RNA, Messenger - metabolism | Autophagy | Brain - metabolism | Gliosis - pathology | Neuroprotective Agents - pharmacology | Dimethyl Fumarate - pharmacology | NF-E2-Related Factor 2 - genetics | Parkinson Disease - metabolism | Neuroprotective Agents - administration & dosage | Disease Models, Animal | Gene Expression | Gliosis - genetics | Parkinson Disease - pathology | Synucleins - genetics | Gliosis - metabolism | RNA, Messenger - genetics | Drug Repositioning | Synucleins - metabolism | Mice, Knockout | Phenotype | Animals | Mice | Dimethyl Fumarate - administration & dosage | Care and treatment | Parkinson's disease | Research | Gene expression | Dimethyl | Neuroprotection | Brain | Therapy | Oxidative stress | Basal ganglia | Multiple sclerosis | Mesencephalon | Toxicity | Substantia nigra | Parkinsons disease | Innovations | Synuclein | Proteins | Neurotoxicity | Autopsy | Movement disorders | Dopamine receptors | Recombinant | Phenotypes | Dopamine | Wound healing | Neurodegenerative diseases | Pharmacology | Inflammation | Disease control | Ganglia | Lewy bodies | Gliosis | Cell death | Phagocytosis | Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 04/2016, Volume 7, Issue 1, p. 11253
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1 - 12
Corpora amylacea (CA) are spherical bodies mainly composed of polyglucans and, to a lesser extent, proteins. They are abundant in brains from patients with... 
Proteins | Cortex (insular) | Protein composition | Neurodegenerative diseases
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22090
Journal Article
Neuroscience, ISSN 0306-4522, 01/2019, Volume 396, pp. 119 - 137
[Display omitted] •BSCL2 expression in human brains decreases with age.•BSCL2 expression correlates with oxidative stress protection and peroxisome biogenesis... 
BSCL2 | seipin | neurodegeneration | peroxisomes | human brain | lipodystrophy | ALPHA | PROLIFERATION | MODEL | NEUROSCIENCES | ENCEPHALOPATHY | PPAR | METABOLISM | GENE-EXPRESSION | DIFFERENTIATION | REVEALS
Journal Article